Myc inhibition by shRNA in the Myc‐amplified pediatric GBM cell line SF188, led to a significant reduction in glutamine consumption and lower levels of the high affinity glutamine importers SLC1A5 and SN2 [76]. Here, MYC is linked to glioblastoma.